Biotech Market News
-
What Is a Biotech Licensing Deal? How Pharma Partnerships Work for Investors
A licensing deal announcement can be one of the most significant catalysts a clinical-stage biotech company produces. When a small biotech licenses rights to one of its drug programs to a large pharmaceutical company, the deal typically brings an immediate cash payment, validation from a sophisticated buyer who has conducted its own due diligence, and…
-
What Is a Binary Event in Biotech? High-Stakes Catalysts Explained
Few events in the financial markets generate the kind of violent, same-day price moves that biotech binary events produce. A Phase 3 trial result, an FDA approval decision, or an AdCom vote can send a stock up 80% or down 70% before most investors have finished their morning coffee. The term ‘binary event’ is one…
-
What Is Cash Runway in Biotech? How to Evaluate a Company’s Financial Health
Most clinical-stage biotech companies generate no revenue. They spend money — sometimes enormous amounts of it — running trials and paying staff, while waiting on FDA decisions that may be years away. The question every investor in these companies needs to ask is simple: how long can they keep the lights on? That question is…